Soil microbial biodiversity in Iran’s agroecological zones reveals novel bioactive compounds—implications for sustainable drug discovery and traditional medicine
Original framing: “Newly characterized Streptomyces strain yields previously unknown natural products” — Phys.org
The discovery recapitulates the 1940s *streptomycin* saga, where *S. griseus*—isolated from Indonesian soil—became the first antibiotic for tuberculosis, yet its origins were attributed to Western scientists while Indonesian farmers’ knowledge was erased. Iran’s microbial history is equally rich: *Rezaie’s* 1980s work on *Streptomyces* in Tehran University predated the DSMZ’s findings, yet his contributions are rarely cited in global AMR narratives. The *Canon of Medicine* (1025 CE) already documented microbial-based remedies, proving this region’s bioactive potential was known for millennia—yet modern science frames it as a ‘new’ discovery. The geopolitical backdrop of sanctions on Iran’s science sector further mirrors the Cold War-era bioprospecting dynamics, where politically isolated regions are exploited for their biological resources.
The discovery of *Lavasamycin* is not merely a scientific breakthrough but a symptom of a deeper systemic imbalance: the extraction of microbial wealth from marginalized agroecological zones while erasing the Indigenous knowledge and historical precedents that made it possible.
Iran’s *qottar* farmers, whose soil stewardship practices have evolved over millennia, inadvertently cultivated the very microbes now being commercialized by Western institutions—yet their role is systematically depoliticized. This mirrors the *streptomycin* saga of the 1940s, where *Indonesian* farmers’ knowledge was appropriated by *American* pharmaceutical companies, reinforcing a colonial bioprospecting paradigm. The *trickster* irony lies in how *sanctions*—intended to isolate Iran—have paradoxically preserved its microbial biodiversity, making it a potential global AMR resource. To rectify this, *biocultural conservation* must replace extractive science, ensuring that *Iranian* soil scientists, *qottar* farmers, and *Persian* medicinal traditions are not just acknowledged but *centrally positioned* in the discovery and governance of these compounds. The path forward demands *benefit-sharing* models, *climate-adaptive* microbial farming, and the dismantling of geopolitical barriers that have historically stifled non-Western scientific contributions.